摘要
Abstract
OBJECTIVE: To evaluate the cost-effectiveness on 3 ginkgo preparations on coronary heart disease (CHD) with angina pectoris (AP). METHODS: A total of 103 cases with the diagnosis standard of angina pectoris were ascribed to 2 mL ginkgo biloba extract for injection (group A, 34 cases), dipyridamole for injection (group B, 35 cases) and 5 mL ginkgo biloba extract for injection (group C, 34 cases), qd, iv.gtt. Respectively. The curative effects were observed analyzed by cost-effectiveness method after 14 days. RESULTS: The effective rates of improving pectoris were 70.59% ,91.43% and 73.53%, the cost for 3 groups were 5 207.86, 3 575.46 and 5 065.06 yuan, and the cost-effectiveness ratios were 7 377.62、3 910.60 and 6 888.43, respectively. CONCLUSION: Compared with groups A and C, group B is superior in terms of the cost-effectiveness ratios.关键词
冠心病心绞痛/银杏叶制剂/银杏达莫/成本-效果分析Key words
Coronary heart disease with angina pectoris/ Ginkgo preparations/ Dipyridamole/ Cost-effectiveness analysis分类
医药卫生
